Table 2.
Characterization of Virus Preparations
| Total |
HCAdV |
Helper Virus |
|||
|---|---|---|---|---|---|
| vp/mL | IU/mL | vp:IU | IU/mL | IU/vp (%) | |
| HCAdV-FTC/CBh-Cas9-VAI-RT-P1-XCp | 1.20E+11 | 5.19E+09 | 23:1 | 1.44E+08 | 0.12 |
| HCAdV-FTC/hAAT-TALEN-S | 3.02E+11 | 1.07E+10 | 28:1 | 2.50E+07 | 0.01 |
Characterization of Virus Preparations
| Total |
HCAdV |
Helper Virus |
|||
|---|---|---|---|---|---|
| vp/mL | IU/mL | vp:IU | IU/mL | IU/vp (%) | |
| HCAdV-FTC/CBh-Cas9-VAI-RT-P1-XCp | 1.20E+11 | 5.19E+09 | 23:1 | 1.44E+08 | 0.12 |
| HCAdV-FTC/hAAT-TALEN-S | 3.02E+11 | 1.07E+10 | 28:1 | 2.50E+07 | 0.01 |